欧盟官方标签名称词汇表条目 6421
CI 47005
本记录确认了用于欧盟化妆品标签标示的官方通用成分名称。它本身并不能确认该物质获准使用、不受限制或安全。
全球证据概览
所解析的身份在 13 个已索引市场数据集中的 5 个有匹配的监管证据:4 条国家记录和 1 条欧盟附件记录。下方列出每项结果和证据缺口。
已检查的市场
13
有证据的市场
5
证据缺口
8
已解析的标识符
7
已解析的物质身份
CAS:8004-92-094891-32-495193-83-268814-04-038615-46-2
EC:305-632-3305-897-5
成分索引记录:
5 个匹配或报告的名称
CI 470051H-Indene-1,3(2H)-dione, 2-(2-quinolinyl)-, sulfonated, sodium salts1H-Indene-1,3(2H)-dione, 2-(2-quinolinyl)-, sulfonated, sodium salts (Food Yellow 13)Acid Yellow 3 Cas No 8004-92-01H-Indene-1,3(2H)-dione, 2-(2-quinolinyl)-, sulfonated, sodium salts (CI 47005)
全部 13 个市场的监管证据
打开每条匹配记录,查看其范围、浓度、条件、警示语和官方来源版本。
滑动或横向滚动以查看数据集覆盖范围和后续操作。
| 市场 | 结果 | 记录 | 数据集 | 含义 / 后续操作 |
|---|---|---|---|---|
| European Union EU | 有条件准用清单匹配 | 1打开记录 1 | Complete annex dataset Regulation (EC) 1223/2009 consolidated to 1 May 2026 | 请查看每条关联记录及其确切条件。 |
| Great Britain GB | Permitted list with conditions | 1打开记录 1 | Complete consolidated annex dataset GB retained Regulation 1223/2009 schedules, effective 15 August 2026 | 请查看每条关联记录及其确切条件。 |
| Canada CA | 未找到匹配项 | 0 | Complete Hotlist snapshot Health Canada Cosmetic Ingredient Hotlist, 13 August 2025 | The Hotlist is an administrative compliance tool, not an exhaustive safety approval list. |
| New Zealand NZ | Permitted list with conditions | 1打开记录 1 | Complete schedules dataset Cosmetic Products Group Standard schedules effective 1 January 2026 | 请查看每条关联记录及其确切条件。 |
| ASEAN ASEAN | Restricted | 1打开记录 1 | Complete regional annex dataset ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026 | 请查看每条关联记录及其确切条件。 |
| China CN | 未找到匹配项 | 0 | Complete prohibited catalogues plus official-source workflow NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025 | IECIC listing is not blanket approval; absence may require the new cosmetic ingredient route, and restrictions are checked separately. |
| Japan JP | 未找到匹配项 | 0 | Complete Standards appendices dataset MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot | The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion. |
| South Korea KR | 未找到匹配项 | 0 | Complete current appendix dataset MFDS Notice 2026-19, effective 18 March 2026 | Korean source wording is canonical and other positive lists/notices may still apply to the formulation. |
| United States US | 未找到匹配项 | 0 | Complete enumerated federal ingredient rules eCFR Title 21 issue date 27 August 2026 | FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety. |
| Australia AU | 未找到匹配项 | 0 | Complete cosmetic-relevant Poisons Standard subset plus official workflow Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 | An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction. |
| Brazil BR | 未找到匹配项 | 0 | Complete prohibited dataset plus current restricted-list workflow ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026 | RDC 1.030/2026 amends rather than replaces the prohibited baseline, and the second restricted-list revision was still under consultation in July 2026. |
| India IN | 未找到匹配项 | 0 | Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4 Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022) | The standards are separate controlled publications; absence from a locally indexed excerpt is not permission. |
| Saudi Arabia SA | Restricted | 1打开记录 1 | Complete official list index SFDA live prohibited/restricted lists, snapshot 30 August 2026 | 请查看每条关联记录及其确切条件。 |
没有与此筛选条件匹配的市场行。
匹配的市场记录和条件
Great Britain
GB retained Regulation 1223/2009 schedules, effective 15 August 2026New Zealand
Cosmetic Products Group Standard schedules effective 1 January 2026ASEAN
ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026Saudi Arabia
SFDA live prohibited/restricted lists, snapshot 30 August 2026附件 II–VI 的精确证据
Annex IV条目 82
打开完整监管记录CI 47005
警示语: Purity criteria as set out in Commission Directive 95/45/EC (E 104)
化学身份与性质

CAS 38615-46-2PubChem CID 19073841
2-(2'-Quinolyl)-1,3-indandione-5,6'-disulfonic acid
- IUPAC 名称
- 2-(1,3-dioxo-5-sulfoinden-2-yl)quinoline-6-sulfonic acid
- 分子式
- C18H11NO8S2
- 分子量
- 433.4 g/mol
- 精确质量
- 432.99260866 Da
- XLogP3
- 0.9
- 拓扑极性表面积
- 173.0 Ų
- 氢键供体
- 2
- 氢键受体
- 9
- 共价单元
- 1
- 已定义的立体中心
- 0
又称
RefChem:249977CBWJDJHHZJWSHU-UHFFFAOYSA-N2-(1,3-Dioxo-5-sulfo-2,3-dihydro-1H-inden-2-yl)quinoline-6-sulfonic acid
外部数据库标识符
- EPA DTXSID:DTXSID20873137
于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 68814-04-0PubChem CID 25113171
C.I. Pigment Yellow 115
- IUPAC 名称
- 2-fluoro-6-[[2-[2-methoxy-4-(methylsulfonylmethyl)anilino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]benzamide
- 分子式
- C22H21FN6O4S
- 分子量
- 484.5 g/mol
- 精确质量
- 484.13290251 Da
- XLogP3
- 3.1
- 拓扑极性表面积
- 160.0 Ų
- 氢键供体
- 4
- 氢键受体
- 9
- 共价单元
- 1
- 已定义的立体中心
- 0
又称
2-Fluoro-6-{[2-({2-Methoxy-4-[(Methylsulfonyl)methyl]phenyl}amino)-7h-Pyrrolo[2,3-D]pyrimidin-4-Yl]amino}benzamide2-fluoro-6-[(2-{[4-(methanesulfonylmethyl)-2-methoxyphenyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]benzamide2-fluoro-6-((2-((2-methoxy-4-((methylsulfonyl)methyl)phenyl)amino)-7H-pyrrolo(2,3-d)pyrimidin-4-yl)amino)benzamide2-fluoro-6-((2-((4-(methanesulfonylmethyl)-2-methoxyphenyl)amino)-7H-pyrrolo(2,3-d)pyrimidin-4-yl)amino)benzamide2-Fluoro-6-[[2-[[2-methoxy-4-[(methylsulfonyl)methyl]phenyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]benzamideRefChem:5725763eljHBL3TSS9HJ
另有 3 个已报告名称
VGYXXQRDIVRILX-UHFFFAOYSA-N2-Fluoro-6-[(2-{4-[(methanesulfonyl)methyl]-2-methoxyanilino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]benzamideBenzamide, 2-fluoro-6-[[2-[[2-methoxy-4-[(methylsulfonyl)methyl]phenyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]-
外部数据库标识符
- EPA DTXSID:DTXSID60920497
于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。
官方来源与范围
导入自委员会实施决定 (EU) 2025/1175(数据集版本 EU 2025/1175)。词汇表为第 19(1)(g) 条所要求的成分表提供通用成分名称;它不是准许清单或安全清单。
打开官方决定